Correlation between genotype and β-lactamases of clinical and environmental strains of Stenotrophomonas maltophilia

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 555-558

  Denton, Miles ^a   Keer, Valerie ^a   Hawkey, Peter M ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFRADINE; CEFTAZIDIME; IMIPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENETIC HETEROGENEITY; GENOTYPE; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0032909078     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.555     Document Type: Article

References (12)

1. Akova, M., Bonfiglio, G. & Livermore, D. M. (1991). Susceptibility to β-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 β-lactamases. Journal of Medical Microbiology 35, 208-13.
2. Saino, Y., Kobayashi, F., Inoue, M. & Mitsuhashi, S. (1982). Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrobial Agents and Chemotherapy 22, 564-70.
3. Saino, Y., Inoue, M. & Mitsuhashi, S. (1984). Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrobial Agents and Chemotherapy 25, 362-5.
4. Cullmann, W. & Dick, W. (1990). Heterogeneity of β-lactamase production in Pseudomonas maltophilia: a nosocomial pathogen. Chemotherapy 36, 117-26.
5. Payne, D. J., Cramp, R., Bateson, J. H., Neale, J. & Knowles, D. (1994). Rapid identification of metallo- and serine β-lactamases. Antimicrobial Agents and Chemotherapy 38, 991-6.
6. Paton, R., Miles, R. S. & Amyes, S. G. B. (1994). Biochemical properties of inducible β-lactamases produced from Xanthomonas maltophilia. Antimicrobial Agents and Chemotherapy 38, 2143-9.
7. Sanschagrin, F., Dusfresne, J. & Levesque, R. C. (1998). Molecular heterogeneity of the L1 metallo-β-lactamase family from Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 42, 1245-8.
8. Walsh, T. R., Hall, L., Assinder, S. J., Nichols, W. W., Cartwright, S. J., MacGowan, A. P. et al. (1994). Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia. Biochimica et Biophysica Acta 1218, 199-201.
9. Mathew, A., Harris, A. M., Marshall, M. J. & Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88, 169-78.
10. Denton, M., Todd, N. J., Kerr, K. G., Hawkey, P. M. & Littlewood, J. M. (1998). Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. Journal of Clinical Microbiology 36, 1953-8.
11. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing D. H. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
12. Walsh, T. R., MacGowan, A. P. & Bennett, P. M. (1997). Sequence analysis and enzyme kinetics of the L2 serine β-lactamase from Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 41, 1460-4.